Executives Depart Cassava, Maker of Disputed Alzheimer’s Drugnews2024-07-18T22:21:49+00:00July 18th, 2024|The New York Times|
Malaria Vaccine Rollout to Africa Is a Cautionary Talenews2024-07-05T04:00:09+00:00July 5th, 2024|The New York Times|
FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’snews2024-07-02T18:58:44+00:00July 2nd, 2024|The New York Times|
Embattled Alzheimer’s Researcher Is Charged With Fraudnews2024-06-28T22:05:18+00:00June 28th, 2024|The New York Times|
New Covid Shots Recommended for Americans 6 Months and Older This Fallnews2024-06-27T23:22:57+00:00June 27th, 2024|The New York Times|
Gilead Shot Provides Total Protection From HIV in Trial of Young African Womennews2024-06-21T23:30:20+00:00June 21st, 2024|The New York Times|
South Africa Runs Out of Insulin Pens as Global Supply Shifts to Weight-Loss Drugsnews2024-06-19T09:02:12+00:00June 19th, 2024|The New York Times|
FDA Advisory Panel Endorses Approval of Alzheimer’s Drug Made by Eli Lillynews2024-06-10T21:05:19+00:00June 10th, 2024|The New York Times|
Abortion Pills May Become Controlled Substances in Louisiananews2024-05-23T01:57:38+00:00May 23rd, 2024|The New York Times|
Study Suggests Genetics as a Cause, Not Just a Risk, for Some Alzheimer’snews2024-05-06T16:19:15+00:00May 6th, 2024|The New York Times|